134 related articles for article (PubMed ID: 27837615)
1. Clinical significance of serum interleukin-17 levels in colorectal cancer patients.
Karabulut S; Usul Afsar C; Karabulut M; Kilic L; Alis H; Kones O; Bilgin E; Faruk Aykan N
J BUON; 2016; 21(5):1137-1145. PubMed ID: 27837615
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
[TBL] [Abstract][Full Text] [Related]
3. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
[TBL] [Abstract][Full Text] [Related]
4. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
6. High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab.
Hara M; Nagasaki T; Shiga K; Takahashi H; Takeyama H
Surg Today; 2017 Apr; 47(4):483-489. PubMed ID: 27549777
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer.
Karabulut M; Afsar CU; Alıs H; Oran E; Karabulut S; Akarsu C; Sahbaz NA; Gümüsoglu AY; Bilgin E; Aykan NF
Mol Clin Oncol; 2017 Nov; 7(5):787-797. PubMed ID: 29142750
[TBL] [Abstract][Full Text] [Related]
8. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
9. Serum IL-17 levels can be diagnostic for gastric cancer.
Karabulut M; Usul Afsar C; Serimez M; Karabulut S
J BUON; 2019; 24(4):1601-1609. PubMed ID: 31646815
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma.
Radosavljevic G; Ljujic B; Jovanovic I; Srzentic Z; Pavlovic S; Zdravkovic N; Milovanovic M; Bankovic D; Knezevic M; Acimovic LJ; Arsenijevic N
Neoplasma; 2010; 57(2):135-44. PubMed ID: 20099977
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of predictive markers for patients with advanced colorectal cancer.
Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B
Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092
[TBL] [Abstract][Full Text] [Related]
12. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
[TBL] [Abstract][Full Text] [Related]
13. Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.
Bruhn MA; Townsend AR; Khoon Lee C; Shivasami A; Price TJ; Wrin J; Arentz G; Tebbutt NC; Hocking C; Cunningham D; Hardingham JE;
Int J Cancer; 2014 Aug; 135(3):731-41. PubMed ID: 24374727
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of preoperative serum levels of IL-12p40 and IL-23 for survival of patients with colorectal cancer.
Stanilov N; Miteva L; Jovchev J; Cirovski G; Stanilova S
APMIS; 2014 Dec; 122(12):1223-9. PubMed ID: 24909386
[TBL] [Abstract][Full Text] [Related]
16. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer.
Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S
J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617
[TBL] [Abstract][Full Text] [Related]
17. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
Hegewisch-Becker S; Graeven U; Lerchenmüller CA; Killing B; Depenbusch R; Steffens CC; Al-Batran SE; Lange T; Dietrich G; Stoehlmacher J; Tannapfel A; Reinacher-Schick A; Quidde J; Trarbach T; Hinke A; Schmoll HJ; Arnold D
Lancet Oncol; 2015 Oct; 16(13):1355-69. PubMed ID: 26361971
[TBL] [Abstract][Full Text] [Related]
18. High VEGF-A level at baseline predicts poor treatment effect of bevacizumab-based chemotherapy in metastatic colorectal cancer: a meta-analysis.
Zhao L; Zhang D; Ma H; Jin M; Huang F; Zhang T
Panminerva Med; 2016 Mar; 58(1):48-58. PubMed ID: 26763741
[TBL] [Abstract][Full Text] [Related]
19. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
20. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.
Sun B; Li Y; Zhou Y; Ng TK; Zhao C; Gan Q; Gu X; Xiang J
J Cell Physiol; 2019 Feb; 234(2):1416-1425. PubMed ID: 30078189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
